期刊文献+

超声评分系统结合血清附睾分泌蛋白4、CA125对卵巢肿瘤的诊断意义 被引量:7

Serum HE4 and serum clinical significance of CA125 in diagnosis of ovarian neoplasms transvaginal color Doppler ultrasound
下载PDF
导出
摘要 目的探讨超声评分系统结合血清附睾分泌蛋白4(human epididymal secretory protein 4,HE4)、CA125检测结果,对卵巢肿瘤的诊断意义。方法选取卵巢癌78例(卵巢癌组),卵巢良性肿瘤102例(卵巢良性肿瘤组),检测两组血清HE4及CA125水平,以80例健康人为对照组,制作受试者工作特征(ROC)曲线,以曲线下面积(AUC)反映诊断的准确性。对两组患者进行超声评分,分别计算超声评分系统与肿瘤标志物联合对卵巢癌诊断的敏感性、特异性。结果卵巢癌组血清HE4及CA125水平明显高于卵巢良性肿瘤组和对照组,差异均有统计学意义(P<0.05);卵巢良性肿瘤组与对照组间比较,HE4差异无统计学意义(P>0.05),CA125差异有统计学意义(P<0.05)。HE4诊断卵巢癌的敏感性、特异性分别为94.3%,96.1%;CA125诊断卵巢癌的敏感性、特异性分别为87.4%,94.2%。HE4联合超声评分系统敏感度为为91.4%;CA125联合超声评分系统为85.7%;HE4、CA125、超声评分系统三项联合检测为96.1%。结论血清HE4、CA125联合超声评分系统诊断卵巢肿瘤的敏感性最高。 Objective To study significance of combined with ultrasound score and serum HE4,CA125 in differentiating malignant from benign ovarian tumor. Methods Senventy-eight cases of epithelial ovarian cancer( ovarian cancer group) and 102 cases of benign ovarian tumor( benign ovarian tumor group) measured the serum level of CA125,results are expressed as median( M) said.In 80 cases of normal people as control( control group). By making the receiver operating characteristic( ROC) curve,the area under the curve( AUC) to reflect the accuracy of diagnosis. At the same time,ultrasonic scoring system scores of the two groups of patients,ultrasound scoring system and different tumor markers combination were calculated on the sensitivity,specificity of diagnosis of ovarian cancer. Results The serum HE4 and CA125 in ovarian cancer is significantly higher than that in benign ovarian tumor group and normal control group,compared the differences were statistically significant( P〈0. 05); Compard ovarian benign tumor group and the normal control group,HE4 showed no statistically significant difference( P〉0. 05),CA125 show a significant difference( P〈0. 05).The specificity and sensitivity of HE4 were 94. 3%,96. 1%; The specificity and sensitivity of CA125 were 87. 4%,94. 2%. HE4CA125,ultrasonic scoring system of combined detection of three kinds of sensitivity of 96. 1%. Conclusions HE4 and CA125 in combination with ultrasonic scoring system for differential diagnosis of the highest sensitivity.
出处 《武警医学》 CAS 2014年第12期1242-1244,共3页 Medical Journal of the Chinese People's Armed Police Force
关键词 人附睾分泌蛋白 CA125 卵巢恶性肿瘤 超声评分系统 human epididymal secretory protein CA125 ovarian cancer color doppler ultrasound
  • 相关文献

参考文献11

  • 1Whitehouse C, Solomon E. Current status of the molec- ular characterization of the ovarian cancer antigen CA125 and implications for its use in clinical screening [J]. Gynecol Onco, 2003, 88: 152-157.
  • 2Cohen L S, Escobar P F, Scharm C, et al. Three di- mension al power doppler ultrasound improves the diag- nostic accuracy for ovarian cancer prediction [ J ] . Gy- necol Onco, 2001, 84(2) : 352-353.
  • 3Valentin L. Limited contribution of Doppler velocimetry to the differential diagnosis of extrauterine pelvie tumors [J ]. Obstet Gyneeol, 1994,83:425-433.
  • 4Sasson A M, Timor I E, Antner A, et al. Transvaginal sonographic characterization of ovarian diseases: Evalu- ation of a new scoring system to predict malignancy [ J]. Obsetet Gynecol, 1991,78:70-76.
  • 5Finkler N I, Benaeerraf B I, Lavin P, et al. Comparison of serum CA125, clinical impression and ultrasound in the preoperative evaluation of ovarian masses [ J ]. Obstet Gynecol, 1988,72 : 659-663.
  • 6Lerner J R,Timor I E,Fedeman A, et al. Transv -aginal uhrasonographic characterization of ovarian masseswith an inproved,werghted scoring system [J ]. Am J Obstet Gynecol, 1994,170:81-87.
  • 7Weber G, Merz E,Bahlmann F, et al. A new so Nnomor- phologic scoring- system (Mainz score)for the assess- ment of ovarian tumors using transvaginal ultrasonogra- phy[ J]. Ultraschall Med, 1999,20( 1 ) :2-8.
  • 8Juan L. A newscoring systemto differentiate benign from nalignant adnexal masses [ J ]. Am J Obstet Gynecol, 2003,34(4) :685-697.
  • 9Karlsen N S, Karlsen M A, Hcgdall C K, et al. HFA Tissue Expression and Serum HFA Levels in Healthy In- dividuals and Patients with Benign or Malignant Tumors: A Systematic Review [ J ]. Cancer Epidemiol Biomarkers Prey ,2014,23 ( 11 ) :2285-2295.
  • 10陈光,谢松元,吴洁,陈娟.卵巢癌97例彩色多普勒超声与CT扫描的诊断价值比较[J].武警医学,2011,22(1):67-68. 被引量:16

二级参考文献7

共引文献15

同被引文献59

  • 1马卓娅,汤华,李欣,刘民,吴海东,王晶.MicroRNA在6种肿瘤细胞中的表达差异[J].中国肿瘤生物治疗杂志,2007,14(3):254-258. 被引量:8
  • 2Barua A, Bitterman P, Bahr JM, et al. Contrast-enhanced sonography depicts spontaneous ovarian cancer at early stages in a preclinical animal model[J]. J Ultrasound Med, 2011, 30(3): 333-345.
  • 3Osaki M, Takeshita F, Sugimoto Y, et al. MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression[J]. Mol Ther, 2011, 19(6): 1123-1130.
  • 4Subbaramaiah K, Howe LR, Bhardwaj P, et al. Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland[J]. Cancer Prev Res (Phila), 2011, 4(3): 329-346.
  • 5Pan D, Pramanik M, Senpan A, et al. Molecular photoacoustic imaging of angiogenesis with integrin-targeted gold nanobeacons[J]. FASEB J, 2011, 25(3): 875-882.
  • 6Winer I, Wang S, Lee YE, et al. F3-targeted cisplatin-hydrogel nanoparticles as an effective therapeutic that targets both murine and human ovarian tumor endothelial cells in vivo[J]. Cancer Res, 2010, 70(21): 8674-8683.
  • 7Barua A, Bitterman P, Bahr JM, et al. Detection of tumor-associated neoangiogenesis by Doppler ultrasonography during early-stage ovarian cancer in laying hens: a preclinical model of human spontaneous ovarian cancer[J]. J Ultrasound Med, 2010, 29(2): 173-182.
  • 8Sobiczewski P, Dańska-Bidzińska A, Rzepka J, et al. Evaluation of selected ultrasonographic parameters and marker levels in the preoperative differentiation of borderline ovarian tumors and ovarian cancers[J]. Arch Gynecol Obstet, 2012, 286(6): 1513-1519.
  • 9Mascilini F, Moruzzi C, Giansiracusa C, et al. Imaging in gynecological disease. 10: Clinical and ultrasound characteristics of decidualized endometriomas surgically removed during pregnancy[J]. Ultrasound Obstet Gynecol, 2014, 44(3): 354-360.
  • 10Shah D, Shah S, Parikh J, et al. Doppler ultrasound: a good and reliable predictor of ovarian malignancy[J]. J Obstet Gynaecol India, 2013, 63(3): 186-189.

引证文献7

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部